|
End-of-day quote
New Zealand S.E.
20/08/2026
|
5-day change | 1st Jan Change | ||
| 4.400 NZD | +0.23% |
|
-2.65% | +30.18% |
| 07-31 | AFT Pharmaceuticals Limited - Shareholder/Analyst Call | |
| 07-31 | New Zealand Shares Fall; AFT Pharmaceuticals Chair to Retire | MT |
| Market Cap | 461M 275M 235M 219M 201M 378M 26.27B 386M 2.6B 1.01B 13.16B 1.03B 1.01B 43.58B | P/E 2027 * |
23.4x | P/E 2028 * | 18.6x |
|---|---|---|---|---|---|
| Enterprise Value | 491M 292M 250M 233M 214M 403M 27.97B 410M 2.77B 1.08B 14.02B 1.1B 1.07B 46.4B | EV / Sales 2027 * |
1.62x | EV / Sales 2028 * | 1.41x |
| Free-Float |
22.37% | Yield 2027 * |
0.74% | Yield 2028 * | 0.95% |
Last Transcript: AFT Pharmaceuticals Limited
| 20/01/24 | Rentevrees zet Bel20 onder druk | |
| 19/01/24 | KBC uitblinker op groene beurs | |
| 19/01/24 | Brusselse beurs opent flink hoger | |
| 19/01/24 | Brussel start handelsdag vermoedelijk in het groen | |
| 19/01/24 | Hyloris gaat samenwerken met AFT Pharmaceuticals |
| 1 day | +0.23% | ||
| 1 week | -2.65% | ||
| Current month | -8.52% | ||
| 1 month | +12.53% | ||
| 3 months | +27.54% | ||
| 6 months | +18.60% | ||
| Current year | +30.18% |
| 1 week | 4.23 |  | 4.45 |
| 1 month | 3.94 | | 4.85 |
| Current year | 3.35 | | 4.85 |
| 1 year | 2.56 | | 4.85 |
| 3 years | 2.37 | | 4.85 |
| 5 years | 2.37 | | 5 |
| 10 years | 1.7 | | 5.65 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marree Atkinson
HRO | Human Resources Officer | - | 04/09/2012 |
Hartley Atkinson
CEO | Chief Executive Officer | - | 04/09/1997 |
Stuart Houliston
DFI | Director of Finance/CFO | - | 15/06/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
David Flacks
CHM | Chairman | - | 22/06/2015 |
Hartley Atkinson
BRD | Director/Board Member | - | 04/09/1997 |
Marree Atkinson
BRD | Director/Board Member | - | 04/09/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 3/7/25 | Buy | Founder | 200,000 | 0.1907% | ||
| 26/6/25 | Free | Founder | 17,755 | 0.0169% | ||
| 2/12/24 | Buy | Founder | 45 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.23% | -2.65% | +69.23% | +27.54% | 273M | |
| -1.50% | +4.26% | +78.68% | +129.15% | 1,141B | |
| -1.09% | +3.08% | +51.06% | +61.43% | 659B | |
| -0.52% | +5.57% | +26.61% | +76.35% | 470B | |
| +1.20% | +2.62% | +41.69% | +46.21% | 366B | |
| -0.61% | +2.10% | +23.43% | +40.38% | 302B | |
| +0.32% | +3.25% | +0.94% | +13.25% | 254B | |
| -1.68% | +4.20% | +46.86% | +67.00% | 239B | |
| -1.10% | -0.70% | -14.31% | -53.04% | 207B | |
| -1.52% | +5.36% | +22.58% | +91.66% | 183B | |
| Average | -0.67% | +3.69% | +34.68% | +49.99% | 382.12B | |
| Weighted average by Cap. | -0.89% | +4.31% | +44.73% | +72.77% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 304M 181M 155M 144M 132M 249M 17.29B 254M 1.71B 668M 8.67B 679M 664M 28.7B | 345M 205M 176M 164M 151M 283M 19.65B 288M 1.95B 759M 9.85B 771M 754M 32.61B |
| Net income | 19.7M 11.72M 10.03M 9.36M 8.59M 16.14M 1.12B 16.46M 111M 43.29M 562M 44M 43.04M 1.86B | 24.81M 14.76M 12.64M 11.79M 10.82M 20.33M 1.41B 20.73M 140M 54.53M 708M 55.43M 54.22M 2.34B |
| Net Debt | 29.84M 17.75M 15.2M 14.18M 13.01M 24.45M 1.7B 24.93M 168M 65.57M 851M 66.65M 65.2M 2.82B | 24.6M 14.63M 12.53M 11.69M 10.73M 20.16M 1.4B 20.55M 139M 54.06M 702M 54.94M 53.75M 2.32B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/08/26 | NZ$4.400 | +0.23% | 52,370 |
| 19/08/26 | NZ$4.390 | +3.29% | 139,745 |
| 18/08/26 | NZ$4.250 | -1.16% | 27,527 |
| 17/08/26 | NZ$4.300 | -2.27% | 8,824 |
| 14/08/26 | NZ$4.400 | -0.68% | 21,830 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- AFT Stock
Select your edition
All financial news and data tailored to specific country editions
